ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000632.1|Brasilicardin_1 # 259 # 1287 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.721	BGC0000632.1|Brasilicardin_1 	259	1287	+	Loose	1000	26.1794	MCR-3.17	31.58	3007278	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGGTGAATTCCGGAGAATGGGTCGACGACCCCGACTTGTCCATGAACACCGTGGCATTTCGCCCGGATCGGCAGCTGGTGGCGAGGGCGGCGGAGGCGGCGGCCATCGCCAACGACTATCCGGACATGACGGCCGCGGGCGCGACCGCCGCGCTGGCCGAGCATCTCGGGCTGCCCGCCGATCATCTGGTGTTCGGGCCGGGATCGGCCGCGCTGTGCCAGCTTCTGCTGCTGGTCTGCTGCGAGCCGGGCGCGCAGGTGGTGCACCAGTGGCCGTCGTTCGAGGGCTATCCGTCGATGATCGGGCACGTGCGCGCCGACGCGGTGCCGGTCGCCCTGGACGGGGTGGACACCGATCTGGACGCGATGGCCGCAGCGGTCACCGACCGGACCGCGGTGGTCATGCTGTGCAATCCGAACAATCCCACCGGCGCGCTGCTGGATCAGCAGCGGCTGCGGCGGTTCCTGGACCGGCTGCCCGACCACGTCACGGTGCTGATCGACGAGGCGTACCGGGATTTCGTGCTCGACCCCGGCTACCGCGACGCGCTCGACCTGGTCCGCGAGGATCCGAGAGTGTGTGTGCTGCGCACGTTTTCGAAGTCCTACCGGCTGGCCGGGCTGCGGATCGGCTACCTCGTCGCCCAGCCCGCGCTGACCGCGCGCCTGGCCGTCCTGCGCATGTTCTTCGCGCCCAGCGCTCCGGCGCAGGCCGCCGCGGTGGCCGCCCTGGCCGGGGTCGCGGAGATGCGGCAGCGGTGCGCGCAGGTCGGCGCGGAGCGAACCCGCCTGCGGGACCTGCTGATCGAGCAGGGCTGGCAGGTTCCGGTGAGCCAGGCCAACTTTCTGTGGGTGCCCACTCCCGACGCGGGCGAATTCACCAGGCACTGCGCCGCCTACGGCCTGCGGGTGCGCGAGTGGGCCGAGCGCGGGGTGCGCGTGACGATCGGCAGTCCGGCGACCAACGACGCGTTCGCGGAGGTGGCCGCCGGATTCCGGGCCGCCGCCCGGCAGGCGGTCGCGCCGTGA	MVNSGEWVDDPDLSMNTVAFRPDRQLVARAAEAAAIANDYPDMTAAGATAALAEHLGLPADHLVFGPGSAALCQLLLLVCCEPGAQVVHQWPSFEGYPSMIGHVRADAVPVALDGVDTDLDAMAAAVTDRTAVVMLCNPNNPTGALLDQQRLRRFLDRLPDHVTVLIDEAYRDFVLDPGYRDALDLVREDPRVCVLRTFSKSYRLAGLRIGYLVAQPALTARLAVLRMFFAPSAPAQAAAVAALAGVAEMRQRCAQVGAERTRLRDLLIEQGWQVPVSQANFLWVPTPDAGEFTRHCAAYGLRVREWAERGVRVTIGSPATNDAFAEVAAGFRAAARQAVAP	MPYILKIKIVPFIFLLAFYFAFMLNWPGVLHFYDIIYKLEGFKLGFAISLPILLVAALNLVFIPFSVRYLVKPFFALLILLSTIVSYAMMKYRVLFDQNMIQNIFETNRNEAFAYLNFPILGWVTIVGFIPAILLFFVEVEYEDKWLNGVITRSLSMLASIIVITVIAALYYQDYVSVGRNNSNLQREIIPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETARGKNFSMNGYEKDTNPFTSNSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNLARNSEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIKPKDYPKFCDKNTCYDEVVLQNLDSEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTIRYTDFVIAEMIAKLKTYEDKYNTALLYVSDHGESLGAMGLYLHGTPYKFAPDDQTRVPMQVWMSPGFIKEKGMNMECLQKNAAANRYSHDNIFSSVLGIWDVKTAIYEQELDIFKQCRNN	63.33	gnl|BL_ORD_ID|4722|hsp_num:0	5883			84	192	colistin A; colistin B
BGC0000632.1|Brasilicardin_4 # 3244 # 4914 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.763	BGC0000632.1|Brasilicardin_4 	3244	4914	+	Loose	600	29.6462	rgt1438	34.55	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGACCACCCGCACGATCGATACCGCGCTCGAGACCGGTGCGGAGGCCGTGCTGCGCCACCGCGCCGCCGACGGGCTGTTCGACTACGACTCCGGGGTCGGCGCGACGCTGGCCACCGCGGGCGCGACTCTCGTTCTGCACCTGCACGATCCGGTCGGCTCCCGCGCGTATGTGACGGGCGGGGTCGCGCACCTGAGCCGGACACAGAACGGCGACGGCGGCTGGGGTTCGGTGCCCGGCCAGCCCACCGAGGCGGTCACCACCGCCATCGCGGCCGCCGTGCTGCACCTGGTGGACGCCGACGGCAGCGGCGACCGCGTGCGGGCCGGGCGGGCCGCGCTGGACCGGCTCGGCGGGCTGTCCGGCATCGCCGACCCCGCGCTGTCGGCGGTGTGCCACCGTTTTCACGCCATGGCCGGGTGGGCGCCGCCCGCGCCGGTTCGGGTGCCGCTGTGGGTGTTCGCGCTGCCGCGGCTGCGGCGCACCCGGATGTCGTTCCGGTCCGGGGTGCTGGCCGCCACCGCGCTCGCCCAGGCGCGCGCCGAACCCGGCGGGCTGCTGCGCCGCCTGATCGACCACGCCGCCACCCCCGCCGCGCTGCGGGTGCTGTACGGCATCCATCGCGACGAGGGCGGCACCGGCGCGTTCGGCGCCGACGCCTGGGCGGCCGGGATGACCGGGTTGGGGCTCGTACGCTCCGGCGCCGCACCGGATCTCACCGAGGCCATCGCGGACTTCCTGCGCCGCAGCGTCTTCGCCGACGGCTCCTGGACGATCGTCGAAATCCGGCTCACCTACACCGGTTTCGCGGCCACCGGCCTGTGCGATGCGGGCTACGGGGCCGATCCGCGGCTGGCGGTGACCGCCGACGGCGTGCGCGCCGCGCAGCTGACCCGGCCGTTCACCATGCTGGACTGCCCGCCCGGCGGCTGGAGCTACTCCGGGCCCGACGGCTGGCCGGTCACACTGGAATCGGCGGAACTGCTGTCGGCGCTGGCGAAAATGCCGGGCGCGGACCGCGATCCGCACGTGGCGCGGGGCGCGCGCTGGCTGGCCGGGCGGCAGGACACCCGCGGCTCGTGGAGCCTGTGGGTGCGCGACACCGCCCTCGCCAACGACGGCCCGTGCCCGTACCTGACCGCGCAGGCCGTCGACGCGCTGCTGGACGCCGGAATCCCACCCGAGGACAACGGGATTCGGCGCGCGGCGCGCTGGCTGGCCGGGGTGCAGCGGCCCGACGGCTCGTTCGAATCGCTGTGGTACCGCGGCCACACCGCCGGGACCGCGCAGGTGATCGGCGCGCTGGCGCGGATCACCGACCCGGCCACCGACCCCACCGTGCGCGGCGGCGTGCGCTGGCTGCTGGCGACCCAGCACTCGGACGGATCGTGGGGTCCCGGCGACGGCCGGGCGGGCTCGGTGGAGGAGACCGCGTGGGCGCTGCGCGCCCTGCTCGAGGCCGGAATCGCCCCCGGCACAGCCGAAATCGACCGCGCCGCGGACTGGCTGCTGGCCCGGCAGCAACCCGACGGGCACTGGCCCGAGGCGCCGGTCAGCGCCTACATCCGGCGCTGCGTGCACTACCCCAACGGCGCGATCACCGCGGGCCTGGCCCTGCGCGCGCTGGCCGCCTATCGCCGCGGCCTCGGCAGGAAGGACGACGATGGCTAG	MTTRTIDTALETGAEAVLRHRAADGLFDYDSGVGATLATAGATLVLHLHDPVGSRAYVTGGVAHLSRTQNGDGGWGSVPGQPTEAVTTAIAAAVLHLVDADGSGDRVRAGRAALDRLGGLSGIADPALSAVCHRFHAMAGWAPPAPVRVPLWVFALPRLRRTRMSFRSGVLAATALAQARAEPGGLLRRLIDHAATPAALRVLYGIHRDEGGTGAFGADAWAAGMTGLGLVRSGAAPDLTEAIADFLRRSVFADGSWTIVEIRLTYTGFAATGLCDAGYGADPRLAVTADGVRAAQLTRPFTMLDCPPGGWSYSGPDGWPVTLESAELLSALAKMPGADRDPHVARGARWLAGRQDTRGSWSLWVRDTALANDGPCPYLTAQAVDALLDAGIPPEDNGIRRAARWLAGVQRPDGSFESLWYRGHTAGTAQVIGALARITDPATDPTVRGGVRWLLATQHSDGSWGPGDGRAGSVEETAWALRALLEAGIAPGTAEIDRAADWLLARQQPDGHWPEAPVSAYIRRCVHYPNGAITAGLALRALAAYRRGLGRKDDDG	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	135.28	gnl|BL_ORD_ID|116|hsp_num:0	134			1017	1173	rifampin; rifaximin; rifabutin; rifapentine
BGC0000632.1|Brasilicardin_5 # 4907 # 6175 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.751	BGC0000632.1|Brasilicardin_5 	4907	6175	+	Loose	600	43.5134	Streptomyces venezuelae rox	26.36	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGCTAGTGGAACCGACGCCGACGCCGTGGTGTGCGGCGCGGGAGCGGGCGGCCTGGCCGCGGCCTGCGCGCTCGCGGCGGCCGGGCTGGCGGTGATCGTCCTGGACAAACAGCGACAGCCGCCGTCGATCGCGAAGGGTGAACTGCTGCAACCGGGTTCGCTCACCGCGCTGGATCGGTGGGGAGTGACTCGACGGCTGCTGGCGGCGGGCGGCGTGGAGATCGACCGGCTGTGCGCCCGCGCGAGCGACGGGCGGGCACTGCTGGAACTGGACTATCCGGGGCTGCTCGGCGGCCGCCGACGGATCCTGTCCGCCGACTACCCGACGATTCTCGCCGCCCTGGCCGACAGCCTGCCGCCGGGCGTGCGGGTGCATCGCGGCGTGCCGGTGCGCGGGCCGCTGCACGACGACACCGGACGGGTGTGCGGAGTCGAGGTGGCCGACGAGCGGCTCGGCAGCGTGCGCGCGCCGCTGGTGGTGGCCGCCGACGGCGCGGCCTCCGGACTGCGCGCGGCGGCGGGGATCGCCGTCGCCCGCACCCAGTATCCGCACCGGCTGGTGTCGTTCGACGTGCCCGGCGCCCGGGACGAGGAATTGACCGCCTACGTCACCGATCGCGGTCTGCGCCTGGTGTATCCGCTGCCGCACGCGCGCACCCGGCTCTACATCCAGGCCGGTCCGCAGGAGCTGCGCGGCCGCGACGACGCGGCCATGCGGCGCTGGGCGGTCGAGGCGACCGCCGGGATCGCGGCCCTGGCCCCGCTCGCCGAGCTGCTGCTCGATCCGCGCACCCAGCGCCAATTGTTCTCCGTGCCACGGTATCTGGTGGACCGGCTGGCGCTGCCCGGCCTGGCGCTGGTGGGCGAGTCCGCGCACGCGGTGCATCCGATGGCCGCGCAGGGCATGAACTCCGCCATCGCCGACGCGGCCGAGCTGGCCGACCGGATCACCGCGGTGGGCGCGGCGGACCCGGCCGCCCTCGATCGGGCGCTGACCGACTACGAGCGGGTCCGGCTGCCGCAGCTGCGGCACGTGGCCACCGTGAGCCACAATGCTTCGCGCATGCTCACCGCGGTCTCGCCGGTGGGGCGCCGGCTCGGGCGGCGGCTGCTGCGCGGCACGGCGAACAATCCGCGGCTGCTGGCGGCGACCTGCCGCAATATCGCCGGGGTGAACCCCGCCCCGCTGGGCATGGTCGACCGGCTCTACCAATTGGGCCTGCTGCCCGCCCAGCGTGGCCGCGACATCGAGGAGGCGATGTGCTGA	MASGTDADAVVCGAGAGGLAAACALAAAGLAVIVLDKQRQPPSIAKGELLQPGSLTALDRWGVTRRLLAAGGVEIDRLCARASDGRALLELDYPGLLGGRRRILSADYPTILAALADSLPPGVRVHRGVPVRGPLHDDTGRVCGVEVADERLGSVRAPLVVAADGAASGLRAAAGIAVARTQYPHRLVSFDVPGARDEELTAYVTDRGLRLVYPLPHARTRLYIQAGPQELRGRDDAAMRRWAVEATAGIAALAPLAELLLDPRTQRQLFSVPRYLVDRLALPGLALVGESAHAVHPMAAQGMNSAIADAAELADRITAVGAADPAALDRALTDYERVRLPQLRHVATVSHNASRMLTAVSPVGRRLGRRLLRGTANNPRLLAATCRNIAGVNPAPLGMVDRLYQLGLLPAQRGRDIEEAMC	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	88.66	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	978	rifampin; rifaximin; rifapentine
BGC0000632.1|Brasilicardin_6 # 6169 # 7377 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.705	BGC0000632.1|Brasilicardin_6 	6169	7377	+	Loose	500	27.335	OXA-404	36.67	3001595	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGCTGACCGAAGAGCACGCCTGGCGGCTGCCGGTGGTGCGCGACGGCGCGTACGACCTGCCCGCCGTCTGCCGGTCCATGCAGCAGGCCGGGCCGATCGTGCCCGCCCGCACCCCGAACGGGAAGACGGTGTGGGTGGTGACCCGGCACGCGGAAGTCCGCCGGGTGCTGGCGGATTCGCGGACCACCGCCGATCGCGCGCACCCGAACTTCCCGTCGTTCGAGCAGTCCGCGGACGCGCCGGTGCTGATCTCCGGGCCGAATCCGTTTCTGGTGTCGATGGATCCGCCCGCGCACACCCGGGCGCGCGGCGATCTGAAGCGGGAGTTCGAGGAGCGGCGCATCCGCGACTACGCGCCGGTGGTGGAGAAGATCATCGCCGAGGCCGTGGGGCAGCTGCGGGCCGGGCCGCGGCCGGTGGATCTGGTGGCGGAGTTCGCGCTGCGGGTGCCGTCGCGGGTCATCTGTGAACTGCTCGGCGTGCCGTATGCCGACCACGACTTCTTCGAATCCCGCACGCCCGCACTGATCGACAACACCGTCACGCCCGAACAGGGCCGGGCCGCGTTCGGCGAGATCCACGAGTACCTCACCGGGCTGGTCGCCGCGCAGGAGGCCGATCCCGGTGACGACATCATCGGCAACTATGTGCGCGCGACCCGCGAACGCGGCGACTACCGGCGCGAAGCCCTGGTGTCGCATGCGTTCCTGCTGCTGATCGCGGGGCACGAGACCACCGCGAATCAGATCGCGCTGAGCGCGCTGGCCCTGATGCAGCGCCCGGAGCTGCGCGAGCATCTCGACGGCGACCCCGTCCGGATGGCGAGCGCGGTGGACGAGATGCTGCGGTATTTCACCATCGTGGACACCGTGTCGCGGGTGGCCACCGCCGATATCGAGATCGGCGGGGTCACCATTCGCGCCGGGGACGGGATCGTGGCCCTGTGCACGATCGCCAACCGCGACCCCGACGTGTATGCCGACCCCGACGAGCTGGATCTCACCCGTGGCAGCCGCAGGCACCTGGCCTTCGGCTTCGGCCCGCACCAGTGCCTCGGCCAGGGCCTGGCCCGCCTGGAACTGGAACTGGCCCTGCGCACCCTGGTCACCGAGCTGCCGGGCATGCGGCTGGCGGTTCCGGCGACGGAATTGGAATTCAAGGGCACCACTTCGGCTTTCGGGGTTCGTCGGCTTCCGGTGACGTGGTAG	MLTEEHAWRLPVVRDGAYDLPAVCRSMQQAGPIVPARTPNGKTVWVVTRHAEVRRVLADSRTTADRAHPNFPSFEQSADAPVLISGPNPFLVSMDPPAHTRARGDLKREFEERRIRDYAPVVEKIIAEAVGQLRAGPRPVDLVAEFALRVPSRVICELLGVPYADHDFFESRTPALIDNTVTPEQGRAAFGEIHEYLTGLVAAQEADPGDDIIGNYVRATRERGDYRREALVSHAFLLLIAGHETTANQIALSALALMQRPELREHLDGDPVRMASAVDEMLRYFTIVDTVSRVATADIEIGGVTIRAGDGIVALCTIANRDPDVYADPDELDLTRGSRRHLAFGFGPHQCLGQGLARLELELALRTLVTELPGMRLAVPATELEFKGTTSAFGVRRLPVTW	MNIKTLLLITSAILISACSPYIVTANPPHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	146.72	gnl|BL_ORD_ID|2301|hsp_num:0	3489			30	117	cloxacillin; oxacillin; cefalotin
BGC0000632.1|Brasilicardin_7 # 7581 # 9218 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.736	BGC0000632.1|Brasilicardin_7 	7581	9218	+	Loose	1000	63.5438	almE	22.16	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGGTGGGATTGAGCAGCGGGTCGCTGGGTGGGGCGATGTGGGAGTGGGCGCGGCGCGGCGGGGATCGGGTCGCGCTGTGGGACGACGCCGGTGCGGTGAGTTACGCGGCGCTGGCGCGGCGGGCCGATGCGCTGGCGGTGGTGTTGCGGGAGGTGGGGATCGGGCGGGGGGATCGGGTGCTGATGCAGCTGCCCAACGGGTGGGAGCTGGTGGTGGGGATGCTGGCGGTGCAGCGGGCCGGGGCGGCGGCGATTCCGGCGCTCATGGGGCATCGGCTGCACGATCTGACGCGGATCGCCGAGACCGCCGGTGTGGCGGCCGTTTTCACCGTCGACACCCATCAGGGGCACGATCATCGCGGCGATGCGCATCGGCTGGCCGCCGGGCGGCCGGTGTTCGTGGCGGGGGAGGACGTGGGCGCCGCCGATATCGATCTGCGCCGCGCGTGCGAGCACCGGGTCGAGGAGGCGGACCGGGTGCGCGCCGACCTGGACCGGCACGACCCGGACGTCGACGAGGACGCGGTGATCCTGCTGTCGGGCGGCACCACCGGCCGTCCCAAGCTGGTGCCGCACACCCATCGCGACTACCGGCACGCCTTCCGGGCGTGCGCGGCCGCGAGCGGGGTGGACGCGGCGACGGTGTATCTGGCGGCATTGCCTGTCGCACACAACTTTTCGCTGGCCTCGCCGGGCATCCTCGGCGTGCTCGACGCCGGGGGCACCGTGGTGCTGGGCCGCTCGCCCAGTCCCGAGGCCGCGTTCGCGGCGATCGCCCGGCACGGGGTGACGATGTCGGCCCTGGTCCCGGCCGTGGCCCGGCGCTGGGCCGAGCATGCCCGGTCCTCGCCCGCCGCCCGCGCCGCGGTGGCCGGTCTGCGCCTGCTGCAACTCGGTGGCGCGGTCACGCCGCCCGACCTCGCCGCCGAGGTGGAAGGGGCCCTCGGGGTCACCGTGCAGCAGGTGTACGGGATGTCGGAGGGGCCGGTGTGCATGACCTCGCCGGACGATCCGCCCGAATTCCGGTACCACACCCAGGGATTGCCGGTCACCGGCGACGAGATCCGCCTGCTCGACACCGCCGGGCAGGAGGCCGACGCGGGAACGGTCGGGGAGGTGGTGACCCGCGGACCGTCGCTGGTGCGCGGCTATCTCGGCGCCGCCGACGACAGCGCGTTCACCGCCGACGGCTGGTACCACACCGGTGATCTGGCCCGCCGCCGCGCGGACGGTCGGATCGACATCGCCGGGCGCATCAAGGATCTCGTCAATCGCGGCGGCGAGAAGATCTCGGTGGTGGAGGTCGAGACGGTGCTGTACGGGCTGCCCGGGATCGCGGCCGCGGCGGTGGTGTCGCTGCCGCACCCGGACCTCGGCGAATGCATCGCGGCCGCCGTCGTTCCCGCCGCCGGGACCGCGGTGGATCTCCCACGGGTCCGGAAGTTCTTCGCCGACACCGGCGTTGCCGCGCACAAGACGCCCGACGCACTGTTCGTCGTGGACGACATCCCGCGGACCGGCATGGGCAAGGTGGATCGCCCGACGCTGCGGGACCGGTTGACGGCGGCGCGATCCGCCGCGAACGACAATGCGAAGGATGGTGTTCGTGCGTGCGGTACGGTCGGCGCTGAGCTGTGA	MVGLSSGSLGGAMWEWARRGGDRVALWDDAGAVSYAALARRADALAVVLREVGIGRGDRVLMQLPNGWELVVGMLAVQRAGAAAIPALMGHRLHDLTRIAETAGVAAVFTVDTHQGHDHRGDAHRLAAGRPVFVAGEDVGAADIDLRRACEHRVEEADRVRADLDRHDPDVDEDAVILLSGGTTGRPKLVPHTHRDYRHAFRACAAASGVDAATVYLAALPVAHNFSLASPGILGVLDAGGTVVLGRSPSPEAAFAAIARHGVTMSALVPAVARRWAEHARSSPAARAAVAGLRLLQLGGAVTPPDLAAEVEGALGVTVQQVYGMSEGPVCMTSPDDPPEFRYHTQGLPVTGDEIRLLDTAGQEADAGTVGEVVTRGPSLVRGYLGAADDSAFTADGWYHTGDLARRRADGRIDIAGRIKDLVNRGGEKISVVEVETVLYGLPGIAAAAVVSLPHPDLGECIAAAVVPAAGTAVDLPRVRKFFADTGVAAHKTPDALFVVDDIPRTGMGKVDRPTLRDRLTAARSAANDNAKDGVRACGTVGAEL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	98.02	gnl|BL_ORD_ID|4935|hsp_num:0	5928			564	1641	colistin A; colistin B
BGC0000632.1|Brasilicardin_8 # 9187 # 10170 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.716	BGC0000632.1|Brasilicardin_8 	9187	10170	+	Loose	450	26.5646	PAM-3	32.0	3007201	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	PAM beta-lactamase	GTGCGTGCGGTACGGTCGGCGCTGAGCTGTGATTACGAGAATGCCGCGACGGCGGTGACCGGGCGGCGCGCCCTGGCCGTCGTGGAATTCGGCGCCGAGGAGGGCCCCGCGGAGCTGCGCGACGGCGTCCCGGTGGTCCGGATCCGCGCCGCCGCAACCGAATCCGCGGGTTTCCGCGAGGTGTGGATCACCGACGGCGACGCGCGGACCGGCCACACCGACGGCCTGGTCTACGCGCACGACGACGATATCCTGTTCTGCGCCGGGCACATTCGGCACGGCGACCGGTACGCGGCACACACCCGCGAGCGGTACGCGGCCGCCTTCGGCCTCGCCGACGCGCTCGGCTACCCCACGCTGGTCCGGATGTGGAACTACGTCGGCGACATCAACGCGGCCAATGCCGACGGCCTGGAGATCTACCGCGACTTCTGCCTGGGACGGGCGGAAGCCTTTGCCGCACACGGGAAGGCGATGCCCGCCGCGACCGGTGTCGGCACGCACGGCAGCGGCGTGGTCTTCTACTTCCTGAGCTGCCGGTCCGGCGGCGTCACCCACATCGAGAACCCGCGCCAGATCCCGGCCTACCGGTATCCGCGCCGCTACGGTCCGAAGGCGCCGACCTTCGCGCGGGCGACCCACCTGCTGCCCGACGGCGGCAGCGACACCCTGTTCGTCTCGGGCACCGCCGCGATCCTCGGGCACGAGACGGTGTGCCCGGGCGATGTGGCGCGGCAGTGCGAGGTGGCGCTCGCCAATATCCGGGAACTGGTCGGCGAGCAGAATCTGGGCCGGTACGGGATCGCCAAACCCTATGGGCTGTCGGCGATTCGGCGCGCCAAGGTGTACGTCCGCCACCGCGAGCACCTGGAGGTGGTGCGCCGGGCCTGCGCCGCCGCGCTGCCGCCGGAGGCCGAGATCGCGTACCTGGTCGTCGACATCTGCCGCAGGGACCTGCTGGTCGAGATCGAGGCCGTGGCATGA	MRAVRSALSCDYENAATAVTGRRALAVVEFGAEEGPAELRDGVPVVRIRAAATESAGFREVWITDGDARTGHTDGLVYAHDDDILFCAGHIRHGDRYAAHTRERYAAAFGLADALGYPTLVRMWNYVGDINAANADGLEIYRDFCLGRAEAFAAHGKAMPAATGVGTHGSGVVFYFLSCRSGGVTHIENPRQIPAYRYPRRYGPKAPTFARATHLLPDGGSDTLFVSGTAAILGHETVCPGDVARQCEVALANIRELVGEQNLGRYGIAKPYGLSAIRRAKVYVRHREHLEVVRRACAAALPPEAEIAYLVVDICRRDLLVEIEAVA	MRLLASLALPLFAANLAVAAPAQLPQLEAYKGLDAWLVPVEPLRISDHVWQIGTASISALLVKTDAGAVLIDGGMPQVADHLLANMKKLGVAPQDVRLILHSHAHIDHVGPLAAIKRATGAALVSNAESAVLLQRGGADDIHFGSGMLFEPIQTDRLVQDGEAVTLGDTTFTVHFTPGHTPGSMSWTWTDTQDGKPLRIAYSDSLSAPGYQLRHNARYPHLVDAFRESFAAVRALPCDLLLTPHAEGSGWDYANAARPHPQPVSCKAYADKAEANLDKMLAEQANKR	113.94	gnl|BL_ORD_ID|4828|hsp_num:0	5814			252	399	
BGC0000632.1|Brasilicardin_10 # 11419 # 12348 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.696	BGC0000632.1|Brasilicardin_10 	11419	12348	+	Loose	270	27.335	mgrA	23.48	3000815	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGGCCCGGCCTTCGGCGTGGTGATCGTCACCTGGAATCCCACGCCCGGCAATGTCGAGCACGCGATATCGCTGGCGCGGCGCGGCATCCAGGTGTGCGTGGTCGACAACACCCCCGTGCCCCAAACCTGGTACGCGCGCCTCACCGACGCGGGAATCACGGTGCTGCACAACGGGAACGAGGGCGGCCTCGGCGGCGGCTTCAACCGCGGCATCGACCTGCTCGCCGGGCGCGGCGCCGAGGTCTTCTTCCTGTTCGACCAGGACTCCGAACCCGGCGACGACTACTTCGACGCCATGCTCGCCACACCCCGGCCCGAAGGGTCGGCCCCGCTGCTGGCCGGTCCGGTGATCTACGACCGCGGCACCGGCATATTCCTGCTCGGCAACGAGGTGGTCGACGCCGACACCATTGCCGCGCACGCGAAGAACGGCCCGCTGGAGGCGCCCTTCGTGATCTCGTCGGGCACCATGATCACCCGGGACGCGTGGCAGGCCATGGGCCCGTTCGACGAGCGCTACATCATCGACTACCTGGACTGGGACCTGTGCCTGCGCGCGACCCGGCGCGGCGTGCGCGTCGTGGTGAATACCGGTGTGGTGCTGCGGCACAGCGTCGGCGCGTTCGAGATCCGGTCGCTGCTCGGCAGATCCATGCTGGCCTTCCACTATCCGCCGTTCCGGCGCTACTACACCGCCCGCAACTGCGTGCACTTCACCACCCGCAATGCCCGCCACCGGGCCGAGTTGCTGCGGCTCAATGCCCACCTGATCTCGAACGTGCTGTCCATCGGCCTGTTCGAGCGCGACCGGACGAGCAAGCTGCTCGCCCTGGCCGCCGGGGTCGTCGACGGTGCGCTCGGCCGCCTCGGCCATTTCACCGATACCCGGCCCCACCTGGCCGCGCTGGTCGCGCGGTCGCGATGA	MTGPAFGVVIVTWNPTPGNVEHAISLARRGIQVCVVDNTPVPQTWYARLTDAGITVLHNGNEGGLGGGFNRGIDLLAGRGAEVFFLFDQDSEPGDDYFDAMLATPRPEGSAPLLAGPVIYDRGTGIFLLGNEVVDADTIAAHAKNGPLEAPFVISSGTMITRDAWQAMGPFDERYIIDYLDWDLCLRATRRGVRVVVNTGVVLRHSVGAFEIRSLLGRSMLAFHYPPFRRYYTARNCVHFTTRNARHRAELLRLNAHLISNVLSIGLFERDRTSKLLALAAGVVDGALGRLGHFTDTRPHLAALVARSR	MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK	210.20	gnl|BL_ORD_ID|133|hsp_num:0	154			105	441	methicillin; ciprofloxacin; acriflavine; tetracycline; daptomycin; moxifloxacin; cefotaxime; norfloxacin; sparfloxacin; moenomycin A1
BGC0000632.1|Brasilicardin_11 # 12378 # 13391 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.759	BGC0000632.1|Brasilicardin_11 	12378	13391	+	Loose	400	31.9574	Erm(30)	27.39	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCCCGACGTGGCAACCGATCCCGACGCGATCCTGGCCCGGCTCACCGACGTGGCCACGCCCTACGCGGTGCGCGCCGCGGTCACCCTCGGCGTGCCGGAGCTGCTCGCCGACGGCCCGGCGTCGCTGGGCGAGCTGGCGGCGGCCACCGGCGTCGACGCCGACACGCTGGGCCGACTGCTGCGGTACCTGGTGGCGCACGGCCTGTTCGGCGAGCCCGAACCGCAGCGCTACGCCCTCACCGACGTCTCGCGCGGCCTGATCGGCGAGGCGGGCGCCGCGCGGCGCGCCTGGATGGACCTGTCCGGCCCCGGTGCGCGCATGGACGCCGCCTACGGCGGCCTGGCGCACGCGCTGCGCACCGGCGGCGACGGCTACAGCGCGGTGCACGGCCGCCCGCTGTGGGAGGACCTGGCCGACAAACCGCGGCTGCGTGCCGAATTCGACACCCTCATGGGCACCGACACCGCCACCGTGGCGCACCTGGTGGCCACCGAGTACGACTGGACCGGCATCGAGCACGTGATCGACGTCGGCGGCGGCGCGGGCATCCTGCTCACCGAGATCCTGCGTGCCCGGCCGAGCATGCGCGGCACGGTCGTGGATCTGCCGCGCGCGGTCGACACCGCGCGGCAGCGGTTCGCCGCCGCCGGGCTCGGCGCCCGCGCCGACGCGATCGGCGGCAGCTTCTTCGAGCCGCTGCCCGCCGGCGCCGACGCCTACATCGTGTCCCGCGTGCTGACCGATTGGAACGACCAAGCGGCGCACGACATTCTGCGCAACTGCGTGGCGGCCGCCCGGCCCGGCGGCCGGGTGCTGATCGTGGAGGTGCTGCCCGACGACAGCGTGCTCGCCCCCGATTCGCCCTACGACCTACAGATGCTCGCCGTGGTCGGCGGGCGGCTGCGCGACGCCGACCAGTTCACCGCCCTCGCCGCCCGCGCCGGTGCGACGGTGGCCGGGGTGCGGCGCTGGGACGGCGGGCTCACCGTCATCGACTGCCGCCCGCGCTGA	MPDVATDPDAILARLTDVATPYAVRAAVTLGVPELLADGPASLGELAAATGVDADTLGRLLRYLVAHGLFGEPEPQRYALTDVSRGLIGEAGAARRAWMDLSGPGARMDAAYGGLAHALRTGGDGYSAVHGRPLWEDLADKPRLRAEFDTLMGTDTATVAHLVATEYDWTGIEHVIDVGGGAGILLTEILRARPSMRGTVVDLPRAVDTARQRFAAAGLGARADAIGGSFFEPLPAGADAYIVSRVLTDWNDQAAHDILRNCVAAARPGGRVLIVEVLPDDSVLAPDSPYDLQMLAVVGGRLRDADQFTALAARAGATVAGVRRWDGGLTVIDCRPR	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	100.30	gnl|BL_ORD_ID|1123|hsp_num:0	1224			30	477	narbomycin; methymycin; pikromycin
BGC0000632.1|Brasilicardin_12 # 13393 # 13761 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000632.1|Brasilicardin_12 	13393	13761	-	Loose	850	23.8682	adeC	37.84	3003811	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	CTGCAGCAGTTCCGGTTTCGCGACACCTCGCTGGAGAGCGCCTTCCAATCGGCCTACGACCAGCTGGATCCCGAACTGGCGCACGCGTTTCGGACGCTGGCCCGGCTGGACCGCCCGGACGCGACCGTGGCGGCGGTCGCGGCCGCGCTCGGCTGCGATCCGGGCGAGGCGGTGCGCCTGTGCGACGCCCTGGTCGATCGCGGCATGCTGGACAGCCCGGCGCCCGGGCGCTACCGCTTCCACGATCTGGTGCGGGTATTCGCCCGCAGCAGACCGGATTCCGACGCATCGGCCGCGATGCGCCGCCCGACCGGGTTCATCGGGGCGCCGAGCCCGGTGATCCTGCCGTGCACGCAGTGTTCCGGATAG	LQQFRFRDTSLESAFQSAYDQLDPELAHAFRTLARLDRPDATVAAVAAALGCDPGEAVRLCDALVDRGMLDSPAPGRYRFHDLVRVFARSRPDSDASAAMRRPTGFIGAPSPVILPCTQCSG	MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKMIAEKSYKEFISDPKLLQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPNNPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYAFAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQAKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRVAGANIGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAETDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYKAGVDSYFTVLDAQRSAYAAQQGLLALEQIKLNNQIEIYKVLGGGISKV	26.24	gnl|BL_ORD_ID|307|hsp_num:0	337			1110	1221	tigecycline; tetracycline
